EMBL Technology Fund II GmbH & Co. KG Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$600,000.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of EMBL Technology Fund II GmbH & Co. KG

Biography of EMBL Technology Fund II GmbH & Co. KG

No biography is available at this moment.

2017-11-20PurchaseX4 Pharmaceuticals, Inc.
XFOR
10 percent owner
40,000
1.3416%
$10.00$400,000-10.41%
Total: 1
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.